Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $2.40, but opened at $2.23. Curaleaf shares last traded at $2.3555, with a volume of 33,131 shares trading hands.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the company. Zacks Research raised Curaleaf from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. ATB Cormark Capital Markets upgraded shares of Curaleaf to an “outperform” rating in a research note on Tuesday, December 2nd. Finally, Alliance Global Partners reiterated a “buy” rating on shares of Curaleaf in a research note on Monday, December 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy”.
Get Our Latest Analysis on Curaleaf
Curaleaf Price Performance
Curaleaf Company Profile
Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.
Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.
Read More
- Five stocks we like better than Curaleaf
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
